- WEBINAR #3 OF A SERIES | October 28 4:00-5:30 PM ET
Are Any of Us Safe from Faulty Generics?
Americans are waking up to the fact that we’ve been tolerating unacceptable failure rates for drugs that are supposed to be safe and effective. Our upcoming webinar examines the changes and incentives needed to improve the drug system’s quality control and supply chains, and ensure everyone can access safe, reliable generic drugs.
Why Watch
Actionable Takeaways to Improve Your Health
Learn the true causes of generic drug shortages.
Gain expert insight into the reforms improving how medicines are made and verified for safety.
Discover actionable steps to put pressure on regulators and pharmaceutical companies.
Meet Our Speakers
Hear from experts advocating for real change to the systems that keep harmful generics on our shelves.
Reshma Ramachandran, M.D.
Assistant Professor of Medicine and Co-Director of Yale CRRIT, Yale School of Medicine
Ramachandran is a primary care physician trained in family medicine and health services researcher. Her research focuses on developing evidence-driven strategies to ensure equitable access to meaningfully effective and safe health innovations in the U.S. and abroad.
Marta Wosińska, Ph.D.
Senior Fellow, Center on Health Policy, The Brookings Institution
Wosińska is a health care economist with expertise in prescription drugs and pharmaceutical supply chains. Her most recent paper, “Rethinking manufacturing quality oversight for prescription drugs,” details how policymakers can balance better quality and costs by adjusting requirements.
Suzanne Robotti
Founder and President,
MedShadow Foundation
Robotti founded MedShadow Foundation in 2013. As a patient safety advocate, she also served on the FDA Advisory Committee on Drug Safety and Risk Management as the only consumer representative alongside doctors and pharmacists from 2017 to 2024.
Creating Safer, Stronger Generic Drug Systems
Discover the practical changes necessary to improve generic drug supply chains—and how your voice can help drive change.
Enhance Infrastructure
Explore the factors, agencies, and processes that drive both shortages and quality issues.
Rethink Regulations
Learn how the FDA, manufacturers, and others can provide solutions, rather than shifting responsibility onto doctors and patients.
Improve Market Dynamics
Understand and fix the economic incentives that perpetuate compromises in drug quality.
Help Us Fix the Broken Generic Drug System
Americans are waking up to the fact that we’ve been tolerating unacceptable failure rates for drugs that are supposed to be safe and improve our health. Advocate for a better system.
Copyright © 2025, MedShadow Foundation. All rights reserved. MedShadow Foundation is a registered 501(c)(3) non-profit organization. MedShadow does not accept advertising or contributions from pharmaceutical companies, medical device manufacturers or political action organizations. This site complies with the HONcode standard for trustworthy health information.